How FDA Plans To Stop Worrying And Love Globalization
Executive Summary
New deputy commissioner Howard Sklamberg tells “The Pink Sheet” that globalization of the drug supply eventually will become more commonplace, and ideally less of a concern, for American consumers.
You may also be interested in...
FDA Talks Drug Safety With China, But Visas Still Elusive For Staff
The agency is unable to place more inspectors in China even as Howard Sklamberg, deputy commissioner for global regulatory operations and policy, visits Beijing.
FDA Talks Drug Safety With China, But Visas Still Elusive For Staff
The agency is unable to place more inspectors in China even as Howard Sklamberg, deputy commissioner for global regulatory operations and policy, visits Beijing.
FDA Talks Drug Safety With China, But Visas For Staff Still Elusive
Agency unable to place more inspectors in China even as Howard Sklamberg visits Beijing.